Biodegradable and biocompatible subcutaneous implants consisted of pH-sensitive mebendazole-loaded/folic acid-targeted chitosan nanoparticles for murine triple-negative breast cancer treatment.

Kefayat, Amirhosein; Hosseini, Maryam; Ghahremani, Fatemeh; Jolfaie, Nafise Arbab; Rafienia, Mohammad

Kefayat, Amirhosein; Hosseini, Maryam; Ghahremani, Fatemeh; Jolfaie, Nafise Arbab; Rafienia, Mohammad.

Afiliación

Kefayat A; Cancer Prevention Research Center, Department of Oncology, Isfahan University of Medical Sciences, 81746-73461, Isfahan, Iran.
Hosseini M; Biosensor Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Ghahremani F; Department of Chemistry, Amirkabir University of Technology (Tehran Polytechnic), 1591634311, Tehran, Iran.
Jolfaie NA; Department of Medical Physics and Radiotherapy, School of Paramedicine, Arak University of Medical Sciences, Arak, Iran.
Rafienia M; Biosensor Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

J Nanobiotechnology ; 20(1): 169, 2022 Mar 31.

Article en En | MEDLINE | ID: mdl-35361226

Asunto(s)

Quitosano; Nanopartículas; Neoplasias de la Mama Triple Negativas; Animales; Quitosano/química; Ácido Fólico/química; Humanos; Concentración de Iones de Hidrógeno; Mebendazol/química; Mebendazol/farmacología; Ratones; Nanopartículas/química; Neoplasias de la Mama Triple Negativas/tratamiento farmacológico

Palabras clave

Chitosan nanoparticles; Folic acid; Mebendazole; Subcutaneous implants; Triple-negative breast cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Quitosano / Nanopartículas / Neoplasias de la Mama Triple Negativas Tipo de estudio: Diagnostic_studies Idioma: En Revista: J Nanobiotechnology Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google